OGEN vs TOST · rev $37.7K vs P/E 161, rev $4.96B
Oragenics Inc (OGEN) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported TOST revenue for 2024-12-31 was $4.96B. Net income was $19.0M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
OGEN currently screens at market cap $2.7M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the OGEN and TOST stock pages for the full models.
Not investment advice.